GLP-1 · Oral formulations
Oral semaglutide for weight loss: Rybelsus, compounded, and what works
Rybelsus is the FDA-approved oral semaglutide, currently approved for type 2 diabetes but frequently prescribed off-label for weight loss. Compounded oral semaglutide is a separate category with less reliable data. Here's how they actually compare to the injection.
Rybelsus: how it actually works
Standard semaglutide is not absorbed orally — stomach acid destroys it. Rybelsus adds sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC), which locally raises pH and lets a small fraction of semaglutide absorb through the stomach wall. Bioavailability is ~1%, which is why the oral dose must be so much higher than injected.
Realistic weight loss on oral semaglutide
- Rybelsus 7 mg: 2-4% average weight loss over 6 months
- Rybelsus 14 mg: 4-8% over 12 months
- Investigational Rybelsus 25 mg: ~10% over 68 weeks (OASIS-1)
- Injectable Wegovy 2.4 mg: 12-15% over 68 weeks
When kindr uses oral vs injectable
Injectable is default for active weight loss. Oral is a reasonable maintenance option after goal weight, or for patients with absolute needle refusal. See our semaglutide guide.
Frequently asked questions
Does oral semaglutide work for weight loss?
Yes but less than the injection. Rybelsus 14 mg produces roughly 4-8% weight loss over 6-12 months versus 12-15% for injectable Wegovy 2.4 mg.
Is Rybelsus FDA-approved for weight loss?
Not yet. It is FDA-approved for type 2 diabetes at 3, 7, and 14 mg. A 25 mg oral dose was tested in the OASIS-1 trial and produced weight loss similar to injectable semaglutide 1.0 mg — an approval application is under FDA review.
How do you take Rybelsus?
On an empty stomach with no more than 4 oz of plain water, at least 30 minutes before food, drink, or other medication. Absorption is very sensitive to protocol.
Is compounded oral semaglutide reliable?
Variable. Rybelsus uses a specific absorption enhancer (SNAC) that makes oral semaglutide viable. Compounded troches or capsules without SNAC have poor bioavailability.
Should I switch from injection to pill?
Usually no, unless needle avoidance is a hard blocker. The injection gives more consistent blood levels and stronger effect. Pill can be useful for maintenance after goal weight is achieved.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.